Findings seen following a hypertensive pregnancy versus usual care<\/p>\n<\/h3>\n
By Lori Solomon HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
FRIDAY, Nov. 17, 2023 (HealthDay News) — The combination of self-monitoring and physician-guided titration of antihypertensive medications is associated with lower postpartum blood pressure following a hypertensive pregnancy compared with usual postnatal outpatient care, according to a study published online Nov. 11 in the\u00a0Journal of the American Medical Association<\/em>\u00a0to coincide with the American Heart Association Scientific Sessions 2023, held from Nov. 11 to 13 in Philadelphia.<\/p>\n Jamie Kitt, D.Phil., from the University of Oxford in the United Kingdom, and colleagues assessed whether remote self-monitoring and physician-guided titration of antihypertensive medications using a Bluetooth-enabled app provides better long-term blood pressure control than usual outpatient care during the first nine months postpartum. The analysis included 200 participants randomly assigned following a hypertensive pregnancy.\u00a0<\/p>\n The researchers found that the 24-hour mean diastolic blood pressure, measured at 249 days postpartum, was 5.8 mm Hg lower in the intervention group (71.2 versus 76.6 mm Hg) than in the control group (between-group difference, \u00e2\u0088\u00925.80 mm Hg). Similar results were seen for 24-hour mean systolic blood pressure (114.0 versus 120.3 mm Hg; between-group difference, \u00e2\u0088\u00926.51 mm Hg).\u00a0<\/p>\n “An intervention that lowers blood pressure by 5 mm Hg would be expected to delay progression to hypertension by many years and, over a lifetime, reduce risk of cardiovascular or cerebrovascular events,” the authors write.<\/p>\n Two authors disclosed financial ties to Sensyne Health.\u00a0<\/p>\n Abstract\/Full Text<\/a><\/p>\n